These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23664986)

  • 1. Evaluation of Brucella abortus S19 vaccines commercialized in Brazil: immunogenicity, residual virulence and MLVA15 genotyping.
    Miranda KL; Poester FP; Minharro S; Dorneles EM; Stynen AP; Lage AP
    Vaccine; 2013 Jun; 31(29):3014-8. PubMed ID: 23664986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic stability of Brucella abortus S19 and RB51 vaccine strains by multiple locus variable number tandem repeat analysis (MLVA16).
    Dorneles EM; de Faria AP; Pauletti RB; Santana JA; Caldeira GA; Heinemann MB; Titze-de-Almeida R; Lage AP
    Vaccine; 2013 Oct; 31(42):4856-9. PubMed ID: 23933375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella abortus S19 rfbD mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice.
    Lalsiamthara J; Kaur G; Gogia N; Ali SA; Goswami TK; Chaudhuri P
    Biologicals; 2020 Jan; 63():62-67. PubMed ID: 31843357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
    Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
    Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical procedures for calculating the residual virulence of Brucella abortus strain 19 (S19) and Brucella melitensis strain Rev 1 vaccines in mice: theoretical basis and practical applications.
    Pouillot R; Grilló MJ; Alabart JL; Garin-Bastuji B; Blasco JM
    Rev Sci Tech; 2003 Dec; 22(3):1051-63. PubMed ID: 15005562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.
    Bosseray N; Plommet M
    Vaccine; 1990 Oct; 8(5):462-8. PubMed ID: 2123586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
    Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
    Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella abortus S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB/c, Swiss and CD-1) and two challenge strains (544 and 2308).
    Miranda KL; Dorneles EM; Pauletti RB; Poester FP; Lage AP
    Vaccine; 2015 Jan; 33(4):507-11. PubMed ID: 25498211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid cycleave PCR method for distinguishing the vaccine strain Brucella abortus A19 in China.
    Nan W; Zhang Y; Tan P; Xu Z; Chen Y; Mao K; Chen Y
    J Vet Diagn Invest; 2016 May; 28(3):214-8. PubMed ID: 27075847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo.
    Caporale V; Bonfini B; Di Giannatale E; Di Provvido A; Forcella S; Giovannini A; Tittarelli M; Scacchia M
    Vet Ital; 2010; 46(1):13-9, 5-11. PubMed ID: 20391363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative genomic analysis between newly sequenced Brucella abortus vaccine strain A19 and another Brucella abortus vaccine S19.
    Wang S; Wang W; Sun K; Bateer H; Zhao X
    Genomics; 2020 Mar; 112(2):1444-1453. PubMed ID: 31454518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.
    Arenas-Gamboa AM; Ficht TA; Kahl-McDonagh MM; Gomez G; Rice-Ficht AC
    Infect Immun; 2009 Feb; 77(2):877-84. PubMed ID: 19047401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.
    Yang X; Thornburg T; Walters N; Pascual DW
    Vaccine; 2010 Jan; 28(4):1069-74. PubMed ID: 19914192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
    Gómez L; Alvarez F; Betancur D; Oñate A
    Vaccine; 2018 May; 36(21):2928-2936. PubMed ID: 29685597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.
    Tibor A; Jacques I; Guilloteau L; Verger JM; Grayon M; Wansard V; Letesson JJ
    Infect Immun; 1998 Nov; 66(11):5561-4. PubMed ID: 9784574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.
    Wang Z; Niu J; Wang S; Lv Y; Wu Q
    Clin Vaccine Immunol; 2013 Feb; 20(2):174-80. PubMed ID: 23239800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accidental exposure to Brucella abortus vaccines and occupational brucellosis among veterinarians in Minas Gerais state, Brazil.
    Pereira CR; de Oliveira IRC; de Oliveira LF; de Oliveira CSF; Lage AP; Dorneles EMS
    Transbound Emerg Dis; 2021 May; 68(3):1363-1376. PubMed ID: 32810924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.